Abstract:Abstract Introduction The epithelial-mesenchymal transition (EMT) pathway contributes to epithelial ovarian cancer (EOC) progression. Previously we identified associations of single nucleotide polymorphisms (SNPs) in EMT-related genes and EOC risk (data not shown). To further investigate the role of EMT-related gene variants in EOC and to derive more reliable risk estimates, we evaluated associations for 795 SNPs from 278 EMT-related genes in a replication study of 43 studies within the Ovarian Cancer Association Consortium (OCAC). Methods The study population included 14,736 cases and 23,448 controls of European ancestry, 89 cases and 200 controls of African ancestry, and 249 cases and 1574 controls of Asian ancestry. The 795 SNPs were genotyped using an Illumina Infinium iSelect BeadChip as part of the Collaborative Oncological Gene-environment Study (COGS). For women of European ancestry, both invasive cancers combined and the four main histological subtypes (serous [n=8,372], endometroid [n=2,068], clear cell [n=1,025] and mucinous [n=943] were analyzed, while for women of African and Asian ancestries only the serous subtype was analyzed. SNP analyses were conducted using unconditional logistic regression under a log-additive model separately for women of each ancestry. All analyses were adjusted for study site and population substructure within each ancestry. Results For women of European ancestry, the strongest evidence of an association for invasive cancers combined was observed for IGF1R rs10794486 (OR=1.05, 95%CI=1.02-1.09, P=0.002), which was also associated with serous (P=0.019), but not the other histological subtypes. In the histological subtype-specific analysis, the most significant association for serous was observed at NRP2 rs3771044 (OR=1.09, 95%CI=1.03-1.15, P=0.00014), for endometroid at rs1770247 (13q31.3, OR=1.16, 95%CI=1.07-1.25, P=0.00028), for clear cell at rs4848300 (2q13, OR=0.84, 95%CI=0.76-0.93, P=0.00099) and for mucinous at SEMA4B rs8030039 (OR=1.09, 95%CI=1.01-1.17, P=0.00019). For women of African ancestry, the strongest association for serous histological subtype was observed at F9 rs6048 (OR=1.71, 95%CI=1.17-2.50, P=0.006). This SNP was not significant in women of European or Asian ancestry. The strongest association for women of Asian ancestry was IGF1R rs10794486 (OR=1.68, 95%CI=1.16-2.45, P=0.007), which was also significant in women of European, but not African, ancestry. Conclusion Findings from this large study provide additional evidence that variants in EMT-related genes may be associated with ovarian cancer risk and that EMT susceptibility loci may differ by ovarian cancer histological subtypes. Furthermore, the findings suggest that susceptibility locus for the serous subtype may be different for women of African ancestry. Future studies are warranted to confirm these findings. Citation Format: Ernest K. Amankwah, Jonathan Tyrer, Hui-Yi Lin, Ya-Yu Tsai, Zhihua Chen, Gang Han, Xiaotao Qu, Ellen Goode, Julie Cunninghan, Edward Iverson, Susan Ramus, Andrew Berchuck, Joellen Schildkraut, Alvaro Monteiro, Simon Gayther, Steven Narod, Paul Pharoah, Thomas A. Sellers, Catherine Phelan. Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1352. doi:10.1158/1538-7445.AM2013-1352

Supplementary Table S4 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S2 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S1 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S3 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Figure S1 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table 2 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk

Identification and Molecular Characterization of a New Ovarian Cancer Susceptibility Locus at 17Q21.31.

Exome Genotyping Arrays to Identify Rare and Low Frequency Variants Associated with Epithelial Ovarian Cancer Risk.

Abstract 2927: MicroRNA Binding Site Polymorphisms Influence Ovarian Cancer Risk in the Collaborative Oncological Gene-Environment Study

Supplementary Figure 1 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk

A Genome-Wide Association Study Identifies a New Ovarian Cancer Susceptibility Locus on 9P22.2.

Microrna Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium

Abstract 1352: Epithelial-mesenchymal Transition (EMT) Gene Variants Influence Epithelial Ovarian Cancer Risk in Women of European, African and Asian Ancestry.

Pathway And Gene Set Analyses For Epithelial Ovarian Cancer (Eoc) Genome-Wide Association Study (Gwas)

A Genome-Wide Association Study Identifies Susceptibility Loci for Ovarian Cancer at 2q31 and 8Q24.

Supplementary Table 1 from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations

Epigenetic Analysis Leads to Identification of HNF1B As a Subtype-Specific Susceptibility Gene for Ovarian Cancer

Assessment of Variation in Immunosuppressive Pathway Genes Reveals TGFBR2 to Be Associated with Risk of Clear Cell Ovarian Cancer.

Abstract 4850: Variation in Circadian Rhythm Genes Influence Epithelial Ovarian Cancer Risk and Invasiveness.

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

Supplementary Table S4 from &lt;i&gt;LIN28B&lt;/i&gt; Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S2 from &lt;i&gt;LIN28B&lt;/i&gt; Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S1 from &lt;i&gt;LIN28B&lt;/i&gt; Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S3 from &lt;i&gt;LIN28B&lt;/i&gt; Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer